Literature DB >> 6677059

[From the study of Fructus schizandrae to the discovery of biphenyl dimethyl-dicarboxylate].

G T Liu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6677059

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


× No keyword cloud information.
  7 in total

1.  Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects.

Authors:  Yong Zeng; Yi-jing He; Fu-yuan He; Lan Fan; Hong-hao Zhou
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

2.  The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.

Authors:  Jing Jin; Hua Sun; Huailing Wei; Gengtao Liu
Journal:  Invest New Drugs       Date:  2007-04       Impact factor: 3.850

3.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

Review 4.  The modification of natural products for medical use.

Authors:  Zongru Guo
Journal:  Acta Pharm Sin B       Date:  2016-11-25       Impact factor: 11.413

5.  A New Nortriterpenoid, a Sesquiterpene and Hepatoprotective Lignans Isolated from the Fruit of Schisandra chinensis.

Authors:  Fenghua Li; Ting Zhang; Hua Sun; Haifeng Gu; Hongqing Wang; Xianming Su; Changkang Li; Baoming Li; Ruoyun Chen; Jie Kang
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

6.  Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse.

Authors:  Wei Song; Junjun Wu; Longjiang Yu; Zhihong Peng
Journal:  Biomed Res Int       Date:  2018-08-23       Impact factor: 3.411

7.  New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.

Authors:  Si-Yuan Pan; Shu-Feng Zhou; Si-Hua Gao; Zhi-Ling Yu; Shuo-Feng Zhang; Min-Ke Tang; Jian-Ning Sun; Dik-Lung Ma; Yi-Fan Han; Wang-Fun Fong; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.